{
    "2020-06-08": [
        [
            {
                "time": "2020-06-15",
                "original_text": "Eli Lilly (LLY) Flat As Market Gains: What You Should Know",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "LLY",
                        "Flat",
                        "Market Gains"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-15",
                "original_text": "Coronavirus update: Global death tally tops 400,000; health experts urge police to stop using tear gas on anti-racism protesters",
                "features": {
                    "keywords": [
                        "Coronavirus",
                        "Global death tally",
                        "tear gas",
                        "anti-racism protesters"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "public policy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-06-15",
                "original_text": "Eli Lilly Kicks Off a Clinical Trial for a Second COVID-19 Antibody Treatment",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Clinical Trial",
                        "COVID-19",
                        "Antibody Treatment"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-15",
                "original_text": "Merck's Antibiotic Recarbrio Gets FDA Nod for New Indication",
                "features": {
                    "keywords": [
                        "Merck",
                        "Antibiotic",
                        "Recarbrio",
                        "FDA",
                        "Nod",
                        "New Indication"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-15",
                "original_text": "Has Eli Lilly and (LLY) Outpaced Other Medical Stocks This Year?",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "LLY",
                        "Medical Stocks",
                        "Outpaced"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-15",
                "original_text": "Lilly to Participate in Goldman Sachs Global Healthcare Conference",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Goldman Sachs",
                        "Global Healthcare Conference"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-15",
                "original_text": "Lilly Announces Start of a Phase 1 Study for its Second Potential COVID-19 Antibody Treatment",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Phase 1 Study",
                        "COVID-19",
                        "Antibody Treatment"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-15",
                "original_text": "Junshi Biosciences Kicks Off Chinaâ€™s First Covid-19 Antibody Trial",
                "features": {
                    "keywords": [
                        "Junshi Biosciences",
                        "Covid-19",
                        "Antibody Trial",
                        "China"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}